The drug Benicar, made by manufacturer Daiichi Sankyo, is used to treat high blood pressure. The active ingredient, olmesartan medoxomil, lowers blood pressure by keeping blood vessels dilated, facilitating blood flow throughout the body. It was approved by the FDA in 2002 and has millions of prescriptions written annually.
In July 2013, the FDA issued warnings and required label changes after studies showed serious gastrointestinal side effects in patients, namely sprue-like enteropathy that can be misdiagnosed as Celiac disease. This condition prevents the intestinal system from absorbing nutrients and can develop months to years after starting the medication, sometimes requiring hospitalization.
Sprue-like enteropathy has not been reported with other drugs of the same class.
Reported side effects from using Benicar:
After the FDA label warnings in 2013, many former Benicar users filed lawsuits against Daiichi Sankyo, citing various forms of negligence.
Complaints by consumers against Benicar manufacturer Daiichi Sankyo include:
Benicar litigation was centralized in MDL in April 2015 before the U.S. District Court for the District of New Jersey.
Patients who have suffered serious injuries after taking Benicar may be able to receive compensation for their medical bills, hospitalization costs, pain and suffering, lost wages, and other damages caused by the drug. Our Benicar lawyers at Kaiser Gornick LLP can review your eligibility to file a lawsuit and work to recover the maximum compensation for you. Learn more about your options for recovery when you talk to one of our attorneys.